Detalles de la búsqueda
1.
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Int J Mol Sci
; 24(16)2023 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628903
2.
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lancet Oncol
; 23(6): 748-757, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617989
3.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411939
4.
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Gastroenterology
; 161(4): 1229-1244.e9, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147519
5.
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.
BMC Cancer
; 21(1): 1238, 2021 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794412
6.
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Br J Cancer
; 123(2): 207-215, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32418993
7.
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 377(4): 352-360, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578607
8.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578639
9.
Cardiopulmonary resuscitation discussions with patients admitted to acute oncology wards: A national audit of current practice.
Eur J Cancer Care (Engl)
; 29(3): e13218, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32215979
10.
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 20(5): 686-700, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987939
11.
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.
BMC Cancer
; 19(1): 967, 2019 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31623580
12.
Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non-muscle-invasive disease.
BJU Int
; 123(6): 947-958, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548196
13.
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
Lancet Oncol
; 19(2): 194-206, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29326030
14.
Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK.
Br J Cancer
; 119(9): 1044-1051, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356125
15.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26510020
16.
Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?
BJU Int
; 121(4): 575-582, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032579
17.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719232
18.
Genomic sequencing in oncology: Considerations for integration in routine cancer care.
Eur J Cancer Care (Engl)
; 31(3): e13584, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35383404
19.
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Lancet Oncol
; 17(3): 378-388, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26794930
20.
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.
Lancet Oncol
; 15(9): 975-85, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24974051